Lipid-Based Nanocarriers for Cutaneous Leishmaniais and Buruli Ulcer Management

E-ISSN： 1873-4286|22|43|6577-6586

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.22, Iss.43, 2017-01, pp. : 6577-6586

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lipid-Based Nanocarriers for RNA Delivery

Current Pharmaceutical Design, Vol. 21, Iss. 22, 2015-01 ,pp. : 3140-3147

Bentham Science Publishers

Access to resources Recommend Favorite

Modification Strategies of Lipid-Based Nanocarriers for Mucosal Drug Delivery

Current Pharmaceutical Design, Vol. 21, Iss. 36, 2015-11 ,pp. : 5198-5211

Bentham Science Publishers

Access to resources Recommend Favorite

In vitro and in vivo studies of lipid-based nanocarriers for oral N₃-o-toluyl-fluorouracil delivery

By Liu Chunxi Liu Donghua Bai Fan Zhang Jian Zhang Na

Drug Delivery, Vol. 17, Iss. 5, 2010-07 ,pp. : 352-363

Informa Healthcare

Access to resources Recommend Favorite

Lipid-based nanocarriers for drug delivery and targeting: a patent survey of methods of production and characterization

By Carbone Claudia Cupri Sarha Leonardi Antonio Puglisi Giovanni Pignatello Rosario

Pharmaceutical Patent Analyst, Vol. 2, Iss. 5, 2013-09 ,pp. : 665-677

Future Science

Access to resources Recommend Favorite

Lipid-based Nanocarriers As An Alternative for Oral Delivery of Poorly Water- Soluble Drugs: Peroral and Mucosal Routes

Current Medicinal Chemistry, Vol. 19, Iss. 26, 2012-09 ,pp. : 4495-4510

Bentham Science Publishers

Access to resources Recommend Favorite